Kitty Sahin

Ms. Sahin offers more than two decades of experience in corporate strategy and business development, having led M&A functions and partnered with senior business executives to drive strategic growth at companies across the life sciences, pharmaceutical and medical technology spaces. In her role at Avantor, Ms. Sahin is responsible for leading the Company's strategy and corporate development team to shape and execute the enterprise growth strategy through organic and inorganic initiatives.

Ms. Sahin most recently served as EVP, Strategy & Business Development at Novanta, a leading supplier of proprietary technologies to medical and advanced industrial equipment OEMs. Previously, she served as Head of Strategy & Business Development, Specialty Diagnostics Group and Senior Director, Corporate Development at Thermo Fisher. She also held senior positions in strategy and corporate development at Covidien, The Watermill Group and Charles River Laboratories as well as roles at Corning and Bain & Company early in her career. Ms. Sahin has a Master of Business Administration from The Wharton School at the University of Pennsylvania and a Bachelor of Arts from Yale University.